PLATINUM-SENSITIVE OVARIAN CANCER
Clinical trials for PLATINUM-SENSITIVE OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-SENSITIVE OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM-SENSITIVE OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep ovarian cancer at bay after chemo
Disease control Recruiting nowThis large, late-stage study is testing whether adding an investigational drug called Rina-S to standard care helps control recurrent ovarian cancer for longer after second-line chemotherapy. It will enroll about 528 women whose cancer returned more than 6 months after their firs…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
New weapon tested in fight against Women's cancers
Disease control Recruiting nowThis study is testing a new drug called IMGN151, both by itself and combined with other cancer treatments, for women with certain gynecologic cancers like ovarian cancer. The main goals are to find safe doses and see if the treatments help control the cancer. About 377 participan…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC